These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 34418636)
101. Reply: Does adjunctive hemoadsorption with CytoSorb® affect survival of COVID-19 patients on ECMO? A critical statement. Putzu A; Schorer R J Crit Care; 2021 Dec; 66():189-190. PubMed ID: 34334278 [No Abstract] [Full Text] [Related]
102. Hemoadsorption in critically ill patients with or without COVID-19: A word of caution. Putzu A; Schorer R J Crit Care; 2021 Oct; 65():140-141. PubMed ID: 34148009 [No Abstract] [Full Text] [Related]
103. Impact of CytoSorb Hemoadsorption on Sedation Requirements in Patients With Severe COVID-19 on Venovenous Extracorporeal Membrane Oxygenation. Lewis TC; Merchan C; Toy B; Goldenberg RM; Geraci TC; Chang SH; Galloway AC; Smith DE; Moazami N ASAIO J; 2021 Aug; 67(8):856-861. PubMed ID: 34339400 [TBL] [Abstract][Full Text] [Related]
104. Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement. Köhler T; Schwier E; Henzler D; Eickmeyer C J Crit Care; 2021 Dec; 66():187-188. PubMed ID: 34330558 [No Abstract] [Full Text] [Related]
105. Can the cytokine adsorber CytoSorb Scharf C; Schroeder I; Paal M; Winkels M; Irlbeck M; Zoller M; Liebchen U Ann Intensive Care; 2021 Jul; 11(1):115. PubMed ID: 34292421 [TBL] [Abstract][Full Text] [Related]
106. Cytokine adsorption and ECMO in patients with COVID-19 - Author's reply. Supady A Lancet Respir Med; 2021 Aug; 9(8):e72-e74. PubMed ID: 34242580 [No Abstract] [Full Text] [Related]
107. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial. Supady A; Weber E; Rieder M; Lother A; Niklaus T; Zahn T; Frech F; Müller S; Kuhl M; Benk C; Maier S; Trummer G; Flügler A; Krüger K; Sekandarzad A; Stachon P; Zotzmann V; Bode C; Biever PM; Staudacher D; Wengenmayer T; Graf E; Duerschmied D Lancet Respir Med; 2021 Jul; 9(7):755-762. PubMed ID: 34000236 [TBL] [Abstract][Full Text] [Related]
108. High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock: A retrospective cohort study. Schultz P; Schwier E; Eickmeyer C; Henzler D; Köhler T J Crit Care; 2021 Aug; 64():184-192. PubMed ID: 33962219 [TBL] [Abstract][Full Text] [Related]
110. Acute Immune Response in Venoarterial and Venovenous Extracorporeal Membrane Oxygenation Models of Rats. Cho HJ; Kayumov M; Kim D; Lee K; Onyekachi FO; Jeung KW; Kim Y; Suen JY; Fraser JF; Jeong IS ASAIO J; 2021 May; 67(5):546-553. PubMed ID: 32826395 [TBL] [Abstract][Full Text] [Related]
111. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Millar JE; Fanning JP; McDonald CI; McAuley DF; Fraser JF Crit Care; 2016 Nov; 20(1):387. PubMed ID: 27890016 [TBL] [Abstract][Full Text] [Related]
112. Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? Authors' response. Supady A; Duerschmied D J Crit Care; 2021 Dec; 66():31-32. PubMed ID: 34418636 [No Abstract] [Full Text] [Related]
116. Hemoperfusion in Cardiac Surgery and ECMO. Abraham P; Mendes V; Kirsch M; Schneider A Contrib Nephrol; 2023; 200():180-191. PubMed ID: 37263244 [TBL] [Abstract][Full Text] [Related]
117. Hemoperfusion in COVID-19. Lertussavavivat T; Srisawat N Contrib Nephrol; 2023; 200():192-200. PubMed ID: 37263252 [TBL] [Abstract][Full Text] [Related]